Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure

Clinical trial NCT06831825 · RECRUITING

Trial details

NCT number: NCT06831825
Sponsor: Medley Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Heart Failure With Reduced Ejection Fraction

Start date: 2025-04-23
Primary completion: 2026-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.